Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Fund Type: Open-End Fund
  • Objective: Foreign Blend
  • Asset Class: Equity
  • Geographic Focus: International

Copeland International Risk Managed Dividend Growth Fund

+ Add to Watchlist

IDVIX:US

11.62 USD 0.05 0.43%

As of 09:29:30 ET on 03/30/2015.

Snapshot for Copeland International Risk Managed Dividend Growth Fund (IDVIX)

Year To Date: +4.12% 3-Month: +3.94% 3-Year: - 52-Week Range: 10.63 - 12.25
1-Month: +0.17% 1-Year: +1.40% 5-Year: - Beta vs SPX: 0.78

Mutual Fund Chart for IDVIX

No chart data available.
  • IDVIX:US 11.62
  • 1M
  • 1Y
Interactive IDVIX Chart

Previous Close

No chart data available.
Interactive Chart
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for IDVIX

Copeland International Risk Managed Dividend Growth Fund is an open-end fund incorporated in the USA. The Fund's objective is to seek long-term capital appreciation and income. The Fund will invest in equities of companies with a proven track record of dividend growth.

Inception Date: 12-17-2012 Telephone: 1-888-9-COPELAND
Managers: ERIK B GRANADE / KENNETH T LEE "KEN"
Web Site: www.copelandcapital.com

Fundamentals for IDVIX

NAV (on 2015-03-30) 11.62
Assets (M) (on 2015-03-30) 32.24
Fund Leveraged N
Minimum Investment 250,000.00
Minimum Subsequent Investment 500.00

Dividends for IDVIX

Dividend Type Omitted
Dividend Frequency Annual
Last Dividend Net -
Dividend Yield (ttm) -

Fees & Expenses for IDVIX

Front Load 0.00
Back Load 0.00
Current Mgmt Fee 1.10
Redemption Fee 1.00
12b1 Fee 0.00
Expense Ratio 1.45

Top Fund Holdings for IDVIX

Filing Date: 02/27/2015
Name Position Value % of Total
Teva Pharmaceutical Industries 20,202 1,151,918 3.784%
Novo Nordisk A/S 21,584 1,034,320 3.398%
BT Group PLC 144,690 1,015,000 3.335%
Capita PLC 54,404 996,069 3.272%
Safran SA 13,664 962,021 3.161%
Eclat Textile Co Ltd 84,000 958,391 3.149%
Gildan Activewear Inc 30,156 917,618 3.015%
Fresenius SE & Co KGaA 15,825 908,172 2.984%
Cheung Kong Infrastructure Hol 105,697 901,688 2.962%
Smith & Nephew PLC 49,176 900,206 2.958%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil